Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

CLOZAPINE 50 MG TABLET

CLOZAPINE
$0.5254per EA

Strength

50 mg/1

Manufacturer

Major Pharmaceuticals

NDC

00904740661

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

CLOZAPINE

Approval Type

Generic (ANDA)

FDA Application

ANDA206433

On Market Since

11/29/2016

Pharmacological Classes

Atypical Antipsychotic

Price History

1W

0.0%

1M

+0.5%

3M

+9.3%

6M

+2.0%

1Y

-3.4%

3Y

N/A

5Y

N/A

All

+15.8%

Generic Alternatives

1 alternative • Same active ingredient

CLOZAPINE 50 MG TABLET
Generic
65862084501•Aurobindo Pharma Limited
$0.5254

Related Drugs

Same classification

QUETIAPINE FUMARATE 25 MG TAB
Generic
00093206301•Teva Pharmaceuticals USA Inc.
$0.0289
per EA
QUETIAPINE FUMARATE 25 MG TAB
Generic
00904663861•Major Pharmaceuticals
$0.0289
per EA
QUETIAPINE FUMARATE 25 MG TAB
Generic
16571071701•Rising Pharma Holdings Inc.
$0.0289
per EA
QUETIAPINE FUMARATE 25 MG TAB
Generic
16571071710•Rising Pharma Holdings Inc.
$0.0289
per EA
QUETIAPINE FUMARATE 25 MG TAB
Generic
16714037501•NorthStar Rx LLC
$0.0289
per EA
QUETIAPINE FUMARATE 25 MG TAB
Generic
16714037502•NorthStar Rx LLC
$0.0289
per EA
QUETIAPINE FUMARATE 25 MG TAB
Generic
16729014501•Accord Healthcare Inc.
$0.0289
per EA
QUETIAPINE FUMARATE 25 MG TAB
Generic
16729014517•Accord Healthcare Inc.
$0.0289
per EA
QUETIAPINE FUMARATE 25 MG TAB
Generic
29300014701•Unichem Pharmaceuticals (USA) Inc.
$0.0289
per EA
QUETIAPINE FUMARATE 25 MG TAB
Generic
29300014710•Unichem Pharmaceuticals (USA) Inc.
$0.0289
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy